Baxter International, Inc. (BAX)
18.70
-3.56
(-16.01%)
USD |
NYSE |
Feb 12, 16:00
18.80
+0.10
(+0.51%)
After-Hours: 20:00
Baxter International Cash from Investing (Quarterly) : -111.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Abbott Laboratories | -- |
| ResMed, Inc. | -50.94M |
| Stryker Corp. | -305.00M |
| iRhythm Holdings, Inc. | -89.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 237.00M |
| Cash from Financing (Quarterly) | -81.00M |
| Free Cash Flow | 235.00M |
| Free Cash Flow Per Share (Quarterly) | 0.2451 |
| Free Cash Flow to Equity (Quarterly) | 139.00M |
| Free Cash Flow to Firm (Quarterly) | 97.76M |
| Free Cash Flow Yield | 2.45% |